Literature DB >> 8389226

Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21.

T Normand1, S Narod, F Labrie, J Simard.   

Abstract

The human estradiol 17 beta-hydroxysteroid dehydrogenase II (17 beta-HSD II) gene has been assigned by somatic cell hybridization to chromosome 17q11-q21, near the region of assignment of the gene BRCA1, which is involved in hereditary breast-ovarian cancer. The nucleotide sequence of 17 beta-HSD II was completely determined in four unrelated individuals. Direct sequencing of PCR fragments that span the complete 17 beta-HSD II gene revealed a total of 11 allelic variants which were due to single base substitutions. The presence of these variants was then studied in twenty six additional unrelated individuals. There were nine frequent and two rare polymorphisms. Seven of the 11 polymorphisms were in complete linkage disequilibrium. These polymorphisms in the 17 beta-HSD II gene provide markers that can be used for the genetic mapping of this locus, and may be used to establish whether 17 beta-HSD II is a candidate gene for hereditary breast-ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389226     DOI: 10.1093/hmg/2.4.479

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

Review 2.  Association between HSD17B1 rs605059 polymorphisms and the risk of uterine diseases: a systemic review and meta-analysis.

Authors:  Xiyan Mu; Xue Du; Kui Yao; Jitong Zhao; Ce Bian; Qiao Wang; Hongwei Ma; Tao Yi; Yang Wu; Xia Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Authors:  Hélène Vézina; Francine Durocher; Martine Dumont; Louis Houde; Csilla Szabo; Martine Tranchant; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Jean Lépine; Heli Nevanlinna; Dominique Stoppa-Lyonnet; David Goldgar; Peter Bridge; Jacques Simard
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

4.  Association of genetic polymorphisms in HSD17B1, HSD17B2 and SHBG genes with hepatocellular carcinoma risk.

Authors:  Lu Shun Zhang; Fang Yuan; Xuan Guan; Juan Li; Xin Lian Liu; Jing Sun; Bo Liu; Wei Ma; Feng Mei Deng
Journal:  Pathol Oncol Res       Date:  2014-02-22       Impact factor: 3.201

5.  CYP2C19 polymorphism increases the risk of endometriosis.

Authors:  Denise Maria Christofolini; Aline Amaro; Fernanda Mafra; Amanda Sonnewend; Bianca Bianco; Caio Parente Barbosa
Journal:  J Assist Reprod Genet       Date:  2014-11-18       Impact factor: 3.412

6.  Interaction of soy and 17beta-HSD1 gene polymorphisms in the risk of endometrial cancer.

Authors:  Qi Dai; Wang-Hong Xu; Ji-Rong Long; Regina Courtney; Yong-Bing Xiang; Qiuyin Cai; Jiarong Cheng; Wei Zheng; Xiao-Ou Shu
Journal:  Pharmacogenet Genomics       Date:  2007-02       Impact factor: 2.089

7.  Site-directed mutagenesis of the putative active site of human 17 beta-hydroxysteroid dehydrogenase type 1.

Authors:  T J Puranen; M H Poutanen; H E Peltoketo; P T Vihko; R K Vihko
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

8.  Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay.

Authors:  A Mannermaa; H Peltoketo; R Winqvist; B A Ponder; H Kiviniemi; D F Easton; M Poutanen; V Isomaa; R Vihko
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

9.  Identification of Differentially Expressed Genes in Porcine Ovaries at Proestrus and Estrus Stages Using RNA-Seq Technique.

Authors:  Songbai Yang; Xiaolong Zhou; Yue Pei; Han Wang; Ke He; Ayong Zhao
Journal:  Biomed Res Int       Date:  2018-02-14       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.